ALB vs PHIO · rev $5.14B vs $10.4M cap
Albemarle Corp (ALB) versus Phio Pharmaceuticals Corp (PHIO) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
Phio Pharmaceuticals Corp (PHIO) is a biotechnology company listed on US.
Latest reported ALB revenue for 2025-12-31 was $5.14B. Net income was -$510.6M. Revenue was down 4.4% from 2024-12-31 to 2025-12-31. ALB currently screens at market cap $8.00B.
PHIO does not have a complete income-statement cache yet.
ALB currently screens at market cap $8.00B. PHIO currently screens at market cap $10.4M.
Not investment advice. Open the ALB and PHIO stock pages for the full models.
Not investment advice.